VILDAPIN 50 mg is an oral antidiabetic medication containing Vildagliptin, a selective Dipeptidyl Peptidase-4 (DPP-4) inhibitor. It is designed to improve glycemic control in patients with Type 2 Diabetes Mellitus by enhancing the body’s natural ability to regulate blood sugar. Vildapin works by increasing the levels of incretin hormones, which stimulate insulin secretion and suppress glucagon production in a glucose-dependent manner.